Visual associations cued recall A Paradigm for Measuring Episodic Memory Decline in Alzheimer's Disease.

Autor: Meyer SR; a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience (MHeNS), Maastricht University , Maastricht , The Netherlands.; b Department of Geriatric Medicine , Medical Center Alkmaar , Alkmaar , The Netherlands., Spaan PE; c University of Amsterdam , Amsterdam , The Netherlands.; d Department of Psychiatry and Medical Psychology , Onze Lieve Vrouwe Gasthuis , Amsterdam , The Netherlands., Boelaarts L; b Department of Geriatric Medicine , Medical Center Alkmaar , Alkmaar , The Netherlands., Ponds RW; a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience (MHeNS), Maastricht University , Maastricht , The Netherlands., Schmand B; c University of Amsterdam , Amsterdam , The Netherlands.; e Department of Medical Psychology , Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands., de Jonghe JF; b Department of Geriatric Medicine , Medical Center Alkmaar , Alkmaar , The Netherlands.
Jazyk: angličtina
Zdroj: Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition [Neuropsychol Dev Cogn B Aging Neuropsychol Cogn] 2016 Sep; Vol. 23 (5), pp. 566-77. Date of Electronic Publication: 2016 Feb 07.
DOI: 10.1080/13825585.2015.1132667
Abstrakt: Repeated measurements of episodic memory are needed for monitoring amnestic mild cognitive impairment (aMCI) and mild Alzheimer's disease (AD). Most episodic memory tests may pose a challenge to patients, even when they are in the milder stages of the disease. This cross-sectional study compared floor effects of the Visual Association Test (VAT) and the Rey Auditory Verbal Learning Test (RAVLT) in healthy elderly controls and in patients with aMCI or AD (N = 125). A hierarchical multiple regression analysis was used to examine whether linear or quadratic trends best fitted the data of cognitive test performance across global cognitive impairment. Results showed that VAT total scores decreased linearly across the range of global cognitive impairment, whereas RAVLT total scores showed a quadratic trend, with total scores levelling off for 90% of aMCI patients and 94% of AD patients. We conclude that the VAT shows few if any floor effects in patients with aMCI and mild AD and is therefore a potentially promising cognitive test for monitoring episodic memory impairment.
Databáze: MEDLINE